Liraltagene Autoleucel - CISMeF

" /> Liraltagene Autoleucel - CISMeF

CISMeF

chu

Liraltagene AutoleucelNCIt concept

Preferred Label : Liraltagene Autoleucel;

UNII : 6NEK9A2UZ5;

Détails

Origin ID

C216001;

chemical_or_drug_affects_cell_type_or_tissue
- Cytotoxic T-Lymphocyte [NCIt concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Sensitization [NCIt concept]
chemical_or_drug_has_physiologic_effect
- Immunopotentiation [NCIt concept]
- T-Cell Activation [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients

Nous contacter.
30/07/2025

[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.